C‐terminal engineered human H‐chain ferritin for peptide loading within the protein nanocage
Protein Science · 2026-12 · 35 (12)
DOI: 10.1002/pro.70839 ↗At a glance
Journal article in Protein Science, published online on 2026-11-05. Written by Michela Buonocore and 9 co-authors. Institution: Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Major MEDLINE topics: Apoferritins, Peptides, Nanostructures. 56 references. The full text is freely available in PubMed Central. Funded by: University of Naples "Federico II".
Abstract (original language)
Self‐assembling proteins are widely used in bionanotechnology due to their biocompatibility, non‐toxicity, structural stability, and easy functionalization. Ferritins (Fts) are particularly attractive systems, as they assemble into highly ordered nanocages with a hollow internal cavity. Their assembly and disassembly can be modulated by various protocols, such as changes in pH or the use of denaturing agents, enabling their application in molecular encapsulation and drug delivery. However, the efficiency of encapsulation remains challenging, often resulting in low or heterogeneous loading and incomplete protein recovery. Here, we load peptides into the core of the human H‐chain ferritin ( hHFt ) by genetically fusing them to the C‐terminus of the Ft subunit, a region facing the inner cavity. As model peptides, we used fragments derived from the SARS ‐ CoV ‐2 Spike protein sharing similar physicochemical properties but different charges. The structure of the functionalized nanocages was assessed using techniques like transmission electron microscopy, native gel electrophoresis, and X‐ray crystallography. High‐resolution structural analysis revealed interesting conformational changes in the hHFt BC ‐loop associated with C‐terminal functionalization, while the overall nanocage architecture is preserved. Additionally, NMR measurements of the transverse relaxation ( T 2 ) of a target peptide demonstrated that the nanocages do not expose the fused peptides under native conditions, but upon disassembly, can efficiently expose them, demonstrating that C‐terminal genetic functionalization of ferritin nanocages is a robust and effective approach for nanobiotechnological applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
- Department of Medical Biotechnology, University of Siena, Policlinico Santa Maria alle Scotte, Siena, Italy.
- Department of Pharmaceutical Sciences for the Environment and Health (DISTABIF), University of Campania "Luigi Vanvitelli", Caserta, CE, Italy.
- CNR, Institute of Biostructures and Bioimaging, CNR, Naples, Italy.
- Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy.
ORCID profiles: Michela Buonocore, Rosanna Lucignano, Giarita Ferraro, Martina Costabile, Annamaria Sandomenico, Gilda D'Urso, Antonella Giarra, Anna Maria D'Ursi, Antonello Merlino, Delia Picone
Funding
- University of Naples "Federico II"
Cite
APA
Buonocore, M., Lucignano, R., Ferraro, G., Costabile, M., Sandomenico, A., D'Urso, G., Giarra, A., D'Ursi, A. M., Merlino, A., & Picone, D. (2026). C‐terminal engineered human H‐chain ferritin for peptide loading within the protein nanocage. Protein Science, 35(12). https://doi.org/10.1002/pro.70839
Vancouver
Buonocore M, Lucignano R, Ferraro G, Costabile M, Sandomenico A, D'Urso G, et al. C‐terminal engineered human H‐chain ferritin for peptide loading within the protein nanocage. Protein Science. 2026;35(12). doi:10.1002/pro.70839
BibTeX
@article{Buonocore2026,
author = {Buonocore, Michela and Lucignano, Rosanna and Ferraro, Giarita and Costabile, Martina and Sandomenico, Annamaria and D'Urso, Gilda and Giarra, Antonella and D'Ursi, Anna Maria and Merlino, Antonello and Picone, Delia},
title = {C‐terminal engineered human H‐chain ferritin for peptide loading within the protein nanocage},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {12},
doi = {10.1002/pro.70839}
}
EUVIMED